Comparing combined strength and endurance exercise programs in postmenopausal women
Compares different ways of combining strength and endurance exercise in postmenopausal women.
Plain-language title generated from the registry record
Registry title: Cardiometabolic Adaptations to Concurrent Training: Effect of Effort Configuration on Postmenopausal Women
Key facts
- Where
- Oleiros, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for physically active postmenopausal women aged 46 to 65. Some may have well-controlled mild hypertension. They will follow a 20-week training program.
- Age
- 46 to 65 years
- Sex
- Women only
- Disease stage
- At least one year since the last menstrual period. Free of cardiovascular (except controlled hypertension), metabolic or renal disease. If hypertensive: well-controlled grade 1 hypertension on a single medication.
- Earlier treatment
- No current or past hormone replacement therapy.
Main reasons for not taking part
- Grade 2 or grade 3 hypertension
- Hypertension treated with more than one medication, or with a drug such as beta-blockers that could affect the body's response to exercise
- Current or past hormone replacement therapy
- Hypertensive response to exercise
- More than three traditional cardiovascular risk factors
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 46 and 65 years old?
Source: NCT07377383, who can take part
Where in Spain
- Faculty of Sport Sciences and Physical Education - UDCOleiros, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Universidade da Coruña
- Trial code
- NCT07377383
- Record updated
- 7 July 2026
- Original description
The main objectives of this project are to assess the effects of a 20-week concurrent training program on neuromuscular adaptations, body composition, cardiometabolic health, quality of life, mood state, physical self-perception, and menopause-related symptoms in physically active postmenopausal women, and to compare the adaptations resulting from different combinations of endurance and resistance training programs with varying effort configurations.Read full original descriptionShow less
Cardiometabolic Adaptations to Resistance and Endurance Exercise: Effects of Effort Configuration in Concurrent Training for Postmenopausal Women
The main objectives of this project are to assess the effects of a 20-week concurrent training program on neuromuscular adaptations, body composition, cardiometabolic health, quality of life, mood state, physical self-perception, and menopause-related symptoms in physically active postmenopausal women, and to compare the adaptations resulting from different combinations of endurance and resistance training programs with varying effort configurations.
Additionally, this project aims to examine the longitudinal interaction and potential interference effects between endurance and resistance training effort configurations throughout the training program and to determine the optimal combination of effort configurations that maximizes health benefits in concurrent training programs for physically active postmenopausal women.
Inclusion: At least one year since the last menstrual period; Physically active, defined as engaging in 150-300 minutes of moderate physical activity per week or at least 75 minutes of vigorous activity per week; Three or fewer traditional cardiovascular risk factors; Asymptomatic and without cardiovascular (except controlled hypertension), metabolic, or renal diseases; In the case of hypertensive participants, well-controlled grade 1 hypertension managed with a single medication.
Exclusion: Current or prior use of hormone replacement therapy; Diagnosis of grade 2 or grade 3 hypertension; Hypertension managed with more than one medication or with a drug that could interfere with cardiovascular responses to exercise (e.g., beta-blockers); Hypertensive response to exercise.